Rare diseases
Investigational molecules
Locations
ORKA-001 in Patients with Moderate-to-Severe Plaque Psoriasis
GermanyStudy of linaprazan glurate and lansoprazole to maintain healing in patients with erosive esophagitis caused by acid reflux disease
BulgariaA study to evaluate the effect of CX11 trometamol monohydrate in patients with type 2 diabetes
PolandEfficacy and Safety of MET097 Once Weekly in People with Overweight or Obesity and Type 2 Diabetes
BulgariaA study to evaluate the efficacy and safety of MET097 in people with obesity or overweight.
BulgariaA study to evaluate the safety and effectiveness of galvokimig in adults with moderate to severe atopic dermatitis
BulgariaA study to evaluate the effect of olpasiran on major cardiovascular events in patients with atherosclerotic cardiovascular disease and high levels of lipoprotein(a)
AustriaEfficacy and Safety Evaluation of Dazodalibep in Patients with Moderate-to-Severe Systemic Sjögren’s Syndrome: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study
BelgiumEvaluation of Dazodalibep Efficacy and Safety in Patients with Moderate-to-Severe Sjögren’s Syndrome: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study
BelgiumStudy of bilastine for effectiveness, safety and quality of life in children aged 6 to 12 years with allergic rhinoconjunctivitis
ItalyA study to evaluate the safety of dazodalibep in patients with Sjögren's Syndrome over a long period of time
BelgiumA Study Testing How Well BAY 3401016 Works and How Safe It Is in Adults Aged 18 to 45 Years with Alport Syndrome
CzechiaTell us about your condition – we search every trial in Europe and connect you with the right site.
